Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of germline <i>RAD51D</i> mutations on breast cancer: Susceptibility to DNA-damaging agents.

Molecular therapy. Oncology·2026
Same author

A multicenter study of laparoscopic versus laparotomic surgery in the treatment of stage I adult granulosa cell and Sertoli-Leydig cell tumors: (LARGES): Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-3005).

Gynecologic oncology·2026
Same author

Cold coagulation revisited: a strategy for high-grade cervical intraepithelial neoplasia in reproductive-age women.

Obstetrics & gynecology science·2026
Same author

PPP1R3C functions as a tumor suppressor in endometrial cancer through promotion of glycogen synthesis.

BMB reports·2026
Same author

Comparison of oncologic outcomes between completion hysterectomy and no completion hysterectomy in patients who achieved complete response and completed childbearing after fertility-sparing treatment for early-stage endometrial cancer: Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-3001).

Gynecologic oncology·2025
Same author

Is restaging surgery quintessential in suspected early-stage epithelial ovarian cancer? An ancillary study of the Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-3002).

Journal of gynecologic oncology·2025

Related Experiment Video

Updated: Mar 31, 2026

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
13:01

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Published on: June 3, 2022

4.7K

Intraoperative Diagnosis Support Tool for Serous Ovarian Tumors Based on Microarray Data Using Multicategory Machine

Jee Soo Park1, Soo Beom Choi, Hee Jung Kim

  • 1*Department of Medical Engineering, Yonsei University College of Medicine; †Department of Medicine, Yonsei University College of Medicine, Seoul, Korea; ‡Graduate Program in Biomedical Engineering, Yonsei University, Seoul, Korea; and Department of §Obstetrics and Gynecology and ∥Pathology, Yonsei University College of Medicine, Seoul, Korea.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|October 30, 2015
PubMed
Summary

This study identifies SNTN and AOX1 as key biomarkers for diagnosing serous borderline ovarian tumors (SBOTs). A new diagnostic tool using these biomarkers offers high accuracy for intraoperative frozen-section analysis.

More Related Videos

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
10:35

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

19.0K
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.9K

Related Experiment Videos

Last Updated: Mar 31, 2026

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
13:01

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Published on: June 3, 2022

4.7K
An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
10:35

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

19.0K
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.9K

Area of Science:

  • Oncology
  • Genomics
  • Biomarker Discovery

Background:

  • Serous borderline ovarian tumors (SBOTs) are a distinct subtype of ovarian carcinoma.
  • Current frozen-section diagnosis for SBOTs has limited accuracy (48-79%), impacting fertility-sparing surgery decisions.
  • Rapid and accurate intraoperative diagnosis is crucial for effective ovarian cancer management.

Purpose of the Study:

  • To develop a rapid, accurate diagnostic tool for SBOTs using DNA microarray technology.
  • To identify novel biomarkers for differentiating between normal ovarian tissue, SBOTs, and serous ovarian carcinoma.
  • To support intraoperative decision-making within a 30-minute timeframe.

Main Methods:

  • Systematic evaluation of 6 machine learning algorithms and 3 feature selection methods.
  • Utilized 5-fold cross-validation and grid search on NCBI microarray data.
  • Validated selected biomarkers (SNTN, AOX1) using RT-qPCR, Western blotting, and immunohistochemistry.

Main Results:

  • Achieved a maximum diagnostic accuracy of 97.3% with an optimal machine learning model.
  • Identified SNTN and AOX1 expression as key features for classifying ovarian tissue types.
  • A multinomial logistic regression model using SNTN and AOX1 achieved 91.9% diagnostic accuracy.

Conclusions:

  • SNTN and AOX1 are identified as potential biomarkers involved in ovarian tumor pathogenesis and progression.
  • The developed equation utilizing SNTN and AOX1 expression offers a novel, accurate diagnostic tool.
  • This tool complements frozen-section diagnosis, providing rapid and reliable results within 30 minutes.